Literature DB >> 19408319

Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from Western Sweden.

Susanne Schmidt1, Dan Mellström, Ensio Norjavaara, S Valter Sundh, Robert Saalman.   

Abstract

BACKGROUND: Low bone mineral density (BMD) has been recognized as a potential problem in children with inflammatory bowel disease (IBD). The aim of the study was to investigate BMD in Swedish children and adolescents with IBD and to evaluate possible factors affecting BMD.
METHODS: To evaluate BMD, all patients (n = 144) underwent a dual-energy X-ray absorptiometry (DXA) of the whole body and the spine. BMD values were expressed as Z-scores using normative pediatric data from Lunar (GE Medical Systems).
RESULTS: In this population-based study, the lowest BMD values were found in the lumbar spine. The entire IBD group showed significantly lower BMD Z-scores of the lumbar spine (L2-L4) in comparison to healthy references (-0.8 standard deviation [SD], range -5.9 to 3.7 SD, P < 0.001). Decreased BMD with a Z-score < -1 SD occurred in 46.7% of the individuals with Crohn's disease (CD) and in 47.0% of those with ulcerative colitis (UC). Low BMD with a Z-score ≤ -2 SD was present in 26.7% of the patients with CD and in 24.1% of the UC patients. In a multiple regression model with BMD lumbar spine as the depending variable, possible factors associated with lower BMD were male gender, low body mass index (BMI), and treatment with azathioprine.
CONCLUSIONS: Low BMD is prevalent in Swedish pediatric patients with IBD. Possible risk factors for lower BMD are male gender, low BMI, and treatment with azathioprine, as a probable marker of disease course severity.
Copyright © 2009 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19408319     DOI: 10.1002/ibd.20962

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  11 in total

1.  Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial.

Authors:  Helen M Pappa; Tracee M Saslowsky; Rajna Filip-Dhima; Diane DiFabio; Hajar Hassani Lahsinoui; Apurva Akkad; Richard J Grand; Catherine M Gordon
Journal:  Am J Gastroenterol       Date:  2011-04-26       Impact factor: 10.864

2.  Musculoskeletal system in children and adolescents with inflammatory bowel disease: normal muscle force, decreased trabecular bone mineral density and low prevalence of vertebral fractures.

Authors:  Klara Maratova; Ondrej Hradsky; Jana Matyskova; Ivana Copova; Ondrej Soucek; Zdenek Sumnik; Jiri Bronsky
Journal:  Eur J Pediatr       Date:  2017-08-24       Impact factor: 3.183

3.  Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients.

Authors:  Bincy P Abraham; Preethi Prasad; Hoda M Malaty
Journal:  Dig Dis Sci       Date:  2014-03-12       Impact factor: 3.199

4.  Skeletal health of children and adolescents with inflammatory bowel disease.

Authors:  Helen Pappa; Meena Thayu; Francisco Sylvester; Mary Leonard; Babette Zemel; Catherine Gordon
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-07       Impact factor: 2.839

Review 5.  Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn's disease: despite temporal changes in disease severity, the need for monitoring remains.

Authors:  Mark D DeBoer; Lee A Denson
Journal:  J Pediatr       Date:  2013-03-22       Impact factor: 4.406

6.  Bone density in peripubertal boys with autism spectrum disorders.

Authors:  Ann M Neumeyer; Amy Gates; Christine Ferrone; Hang Lee; Madhusmita Misra
Journal:  J Autism Dev Disord       Date:  2013-07

7.  Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease.

Authors:  Mostafa Abdel-Aziz El-Hodhod; Ahmad Mohamed Hamdy; Amal Ahmed Abbas; Sherine George Moftah; Alhag Ahmed Mohamed Ramadan
Journal:  BMC Gastroenterol       Date:  2012-05-02       Impact factor: 3.067

8.  Variation in inflammatory bowel disease care among saudi pediatric gastroenterologists.

Authors:  Ahmed A Al-Sarkhy
Journal:  Saudi J Gastroenterol       Date:  2017 Jan-Feb       Impact factor: 2.485

9.  Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease.

Authors:  Hye-Young Jin; Jae-Sang Lim; Yena Lee; Yunha Choi; Seak-Hee Oh; Kyung-Mo Kim; Han-Wook Yoo; Jin-Ho Choi
Journal:  BMC Pediatr       Date:  2021-01-14       Impact factor: 2.125

10.  Clinical practice guidelines for optimizing bone health in Korean children and adolescents.

Authors:  Young Ah Lee; Ahreum Kwon; Jae Hyun Kim; Hyo-Kyoung Nam; Jae-Ho Yoo; Jung Sub Lim; Sung Yoon Cho; Won Kyoung Cho; Kye Shik Shim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2022-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.